Notice of Annual General Meeting/Proxy Form
Released
Released
Announcement PDF
Sultan Resources Limited
(ACN 623 652 522)
NOTICE OF ANNUAL GENERAL MEETING AND
EXPLANATORY MEMORANDUM
Thursday, 23 November 2023
10:00am WST
Mirador Corporate, Suite 11, Level 2, 23 Railway Road
Subiaco, Western Australia 6008
The Annual Report is available online at www.sultanresources.com.au
This Notice of Annual General Meeting and Explanatory Memorandum should be read in its
entirety. If Shareholders are in doubt as to how to vote, they should seek advice from their
accountant, solicitor or other professional adviser without delay.
Should you wish to discuss any matter please do not hesitate to contact the Company by
telephone on +61 8 6559 1792.
NOTICE OF MEETING
Notice is given that the Annual General Meeting of Shareholders of Sultan Resources Limited
(Company) will be held at Mirador Corporate, Suite 11, Level 2, 23 Railway Road, Subiaco, Western
Australia 6008 on Thursday 23 November 2023 commencing at 10:00am WST (Meeting).
The Explanatory Memorandum to this Notice provides additional information on matters to be
considered at the Meeting. The Explanatory Memorandum and the Proxy Form form part of this
Notice.
The Directors have determined pursuant to regulation 7.11.37 of the Corporations Regulations 2001
(Cth) that the persons eligible to vote at the Meeting are those who are registered as Shareholders
at 4:00pm WST on Tuesday, 21 November 2023.
Terms and abbreviations used in this Notice and Explanatory Memorandum are defined in
Schedule 1.
AGENDA
Annual Report
To table and consider the Annual Report of the Company and its controlled entities for the financial
year ended 30 June 2023, which includes the Financial Report, the Directors’ Report and the
Auditor’s Report.
1.
Resolution 1 – Adoption of Remuneration Report
To consider and, if thought fit, to pass the following resolution as an ordinary resolution:
“That, for the purposes of section 250R(2) of the Corporations Act and for all other purposes,
the Remuneration Report that forms part of the Directors’ Report for the financial year ended
30 June 2023 be adopted by the Shareholders on the terms and conditions in the Explanatory
Memorandum.”
Please note that a vote on this Resolution is advisory only and does not bind the Directors or
the Company.
Voting Prohibition
In accordance with section 250R of the Corporations Act, a vote on this Resolution must not be cast (in any
capacity) by, or on behalf of the following persons:
(a)
a member of the Key Management Personnel whose remuneration details are included in the
Remuneration Report; or
(b)
a Closely Related Party of such member.
However, a vote may be cast by such a person (the voter) described above if:
(a)
the person is acting as a proxy and the Proxy Form specifies how the proxy is to vote, and the vote is
not cast on behalf of a person who is otherwise excluded from voting on this Resolution as described
above; or
(b)
the person is the Chair voting an undirected proxy which expressly authorises the Chair to vote on a
resolution connected with the remuneration of a member of the Key Management Personnel.
2.
Resolution 2 – Re-election of Director – David Lees
To consider and, if thought fit, to pass with or without amendment, the following resolution as
an ordinary resolution:
“That, for the purpose of clause 6.3 of the Constitution, David Lees, a Director, retires by
rotation, and being eligible for re-election, is elected as a Director with immediate effect.”
3.
Resolution 3 – Approval of 10% Placement Facility
To consider and, if thought fit, to pass with or without amendment, the following resolution as
a special resolution:
“That, pursuant to and in accordance with Listing Rule 7.1A and for all other purposes,
Shareholders approve the issue of Equity Securities up to 10% of the issued capital of the
Company (at the time of issue) calculated in accordance with the formula prescribed in Listing
Rule 7.1A.2 and on terms and conditions in the Explanatory Memorandum.”
Voting Exclusion
The Company will disregard any votes cast in favour of this Resolution by or on behalf of:
(a)
any person who is expected to participate in, or who will obtain a material benefit as a result of, the
proposed issue (except a benefit solely by reason of being a holder of ordinary securities in the
Company); or
(b)
any Associate of that person or those persons.
However, this does not apply to a vote cast in favour of the Resolution by:
4.
(a)
a person as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with
directions given to the proxy or attorney to vote on the Resolution in that way; or
(b)
the Chair as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with
a direction given to the Chair to vote on the Resolution as the Chair decides; or
(c)
a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a
beneficiary provided the following conditions are met:
(i)
the beneficiary provides written confirmation to the holder that the beneficiary is not excluded
from voting, and is not an associate of a person excluded from voting, on this Resolution; and
(ii)
the holder votes on this Resolution in accordance with directions given by the beneficiary to
the holder to vote in that way.
Resolution 4 – Approval to Issue Director Options to Mr. Jeremy
King
To consider, and if thought fit, to pass with or without amendment, the following resolution
as an ordinary resolution:
“That for the purposes of ASX Listing Rule 10.11, and for all other purposes, approval is given
for the Company to issue of 1,250,000 Director Options to Mr Jeremy King (and/or his
nominee(s)) on the terms and conditions set out in the Explanatory Memorandum.
Voting Exclusion Statement
The Company will disregard any votes cast in favour of:
(a) Mr Jeremy King (and/or his nominees(s)) and any other persons who will obtain a material benefit as a result
of the issue of the securities (except a benefit solely by reason of being a holder of ordinary securities in the
Company); or
(b) an associate of that person or those persons;
However, this does not apply to a vote cast in favour of these Resolutions by:
(a) a person as a proxy or attorney for a person who is entitled to vote on these Resolutions, in accordance with
directions given to the proxy or attorney to vote on these Resolutions in that way;
(b) the Chair as proxy or attorney for a person who is entitled to vote on these Resolutions, in accordance with
a direction given to the Chair to vote on these Resolutions as the Chair decides; or
(c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary
provided the following conditions are met:
(i)
(ii)
the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from
voting, and is not an associate of a person excluded from voting, on these Resolutions; and
the holder votes on these Resolutions in accordance with directions given by the beneficiary to the
holder to vote in that way.
Voting Prohibition Statement:
In accordance with section 224 of the Corporations Act, a vote on this Resolution must not be cast (in any
capacity) by or on behalf of a related party to whom the Resolution would permit a financial benefit to be given,
or an associate of such a related party (Resolution 4 Excluded Party). However, this prohibition does not
apply if the vote is cast by a person as proxy appointed by writing that specifies how the proxy is to vote on the
Resolution and it is not cast on behalf of a Resolution 4 Excluded Party.
In accordance with section 250BD of the Corporations Act, a person appointed as a proxy must not vote, on the
basis of that appointment, on this Resolution if:
(a)
(b)
the proxy is either:
(i)
a member of the Key Management Personnel; or
(ii)
a Closely Related Party of such a member; and
the appointment does not specify the way the proxy is to vote on this Resolution.
Provided the Chair is not a Resolution 4 Excluded Party, the above prohibition does not apply if:
(c)
the proxy is the Chair; and
(d)
the appointment expressly authorises the Chair to exercise the proxy even though this Resolution is
connected directly or indirectly with remuneration of a member of the Key Management Personnel.
Dated 20 October 2023
BY ORDER OF THE BOARD
Hannah Cabatit
Company Secretary
EXPLANATORY MEMORANDUM
1.
Introduction
This Explanatory Memorandum has been prepared for the information of Shareholders of the
Company in connection with the business to be conducted at the Meeting to be held at Suite
11, Level 2, 23 Railway Road, Subiaco, Western Australia 6008 on Thursday, 23 November
2023 commencing at 10:00am (WST).
This Explanatory Memorandum should be read in conjunction with and forms part of the
accompanying Notice. The purpose of this Explanatory Memorandum is to provide
information to Shareholders in deciding whether or not to pass the Resolutions in the Notice.
A Proxy Form is located at the end of the Explanatory Memorandum.
2.
Action to be taken by Shareholders
Shareholders should read the Notice and this Explanatory Memorandum carefully before
deciding how to vote on the Resolutions.
Proxies
A Proxy Form is attached to the Notice. This is to be used by Shareholders if they wish to
appoint a representative (a proxy) to vote in their place. All Shareholders are invited and
encouraged to participate in the Meeting and are encouraged to lodge a directed Proxy Form
to the Company in accordance with the instructions thereon. Lodgement of a Proxy Form will
not preclude a Shareholder from attending and voting at the Meeting.
Please note that:
(a)
a member of the Company entitled to attend and vote at the Meeting is entitled to
appoint a proxy;
(b)
a proxy need not be a member of the Company; and
(c)
a member of the Company entitled to cast two or more votes may appoint two proxies
and may specify the proportion or number of votes each proxy is appointed to
exercise, but where the proportion or number is not specified, each proxy may
exercise half of the votes.
Shareholders and their proxies should be aware that:
(a)
If proxy holders vote, they must cast all directed proxies as they are directed to; and
(b)
Any directed proxies which are not voted will automatically default to the Chair, who
must vote the proxies as directed.
Further details are set out below.
Proxy vote if appointment specifies way to vote
Section 250BB(1) of the Corporations Act provides that an appointment of a proxy may
specify the way the proxy is to vote on a particular resolution and, if it does:
(c)
the proxy need not vote on a show of hands, but if the proxy does so, the proxy must
vote that way (i.e. as directed); and
(d)
if the proxy has 2 or more appointments that specify different ways to vote on the
resolution – the proxy must not vote on a show of hands; and
(e)
if the proxy is the Chair of the meeting at which the resolution is voted on – the proxy
must vote on a poll, and must vote that way (i.e. as directed); and
(f)
if the proxy is not the Chair – the proxy need not vote on the poll, but if the proxy does
so, the proxy must vote that way (i.e. as directed).
Transfer of non-chair proxy to Chair in certain circumstances
Section 250BC of the Corporations Act provides that, if:
(g)
an appointment of a proxy specifies the way the proxy is to vote on a particular
resolution at a meeting of the Company's members; and
(h)
the appointed proxy is not the Chair of the meeting; and
(i)
at the meeting, a poll is duly demanded, or is otherwise required under section
250JA,on the question that the resolution be passed; and
(j)
either of the following applies:
(i)
if a record of attendance is made for the meeting - the proxy is not recorded
as attending;
(ii)
the proxy does not vote on the resolution,
the Chair of the meeting is taken, before voting on the resolution closes, to have been
appointed as the proxy for the purposes of voting on the resolution at the meeting.
The enclosed Proxy Form provides further details on appointing proxies and lodging Proxy
Forms.
Proxy Holders and Voting Instructions
If the Chair is appointed as your proxy and the Chair is not directed how to vote, you are
authorising the Chair to cast your undirected vote on all proposed resolutions.
If a member of the Company’s Key Management Personnel, or a Closely Related Party of
such member, is appointed as your proxy, they will not be able to vote your proxy on
Resolution 1 and Resolution 4, unless you direct them how to vote
If you intend to appoint a member of the Company’s Key Management Personnel, or a
Closely Related Party of such member, or the Chair, as your proxy, you are encouraged to
direct them how to vote on Resolution 1 and Resolution 4, by marking “For”, “Against” or
“Abstain” for that resolution.
Submit your Proxy Vote Online
2.3.1 Online
Vote online at https://investor.automic.com.au/#/loginsah and simply follow the instructions
on the enclosed proxy form.
2.3.2 By Paper
If you do not wish to vote online, then it is necessary to complete in accordance with the
detailed instructions set out on the enclosed Proxy Form.
The return of your completed form (ONLY if you do NOT vote online) can be done by one of
the following ways:
3.
BY MAIL
GPO Box 5193, Sydney NSW 2001
BY FAX
+61 2 8583 3040
Annual Report
There is no requirement for Shareholders to approve the Annual Report.
Shareholders will be offered the following opportunities:
(a)
discuss the Annual Report which is available online at www.sultanresources.com.au;
(b)
ask questions or make comment on the management of the Company;
(c)
ask the auditor questions about the conduct of the audit and the preparation and
content of the Auditor’s Report.
In addition to taking questions at the Meeting, written questions to the Chair about the
management of the Company, or to the Company’s auditor about:
(a)
the preparation and the content of the Auditor’s Report; and
(b)
the conduct of the audit;
(c)
accounting policies by the Company in relation to the preparation of the financial
statements; and
(d)
the independence of the auditor in relation to the conduct of the audit,
may be submitted no later than 5 Business Days before the Meeting to the Company
Secretary at the Company’s registered office.
4.
Resolution 1 – Adoption of Remuneration Report
Section 250R(2) of the Corporations Act provides that the Company is required to put the
Remuneration Report to the vote of Shareholders. The Directors’ Report contains the
Remuneration Report which sets out the remuneration policy for the Company and reports
the remuneration arrangements in place for the executive Directors, specified executives and
non-executive Directors.
Section 250R(3) of Corporations Act provides that Resolution 1 is advisory only and does not
bind the Directors of the Company of itself, a failure of Shareholders to pass Resolution 1 will
not require the Directors to alter any of the arrangements in the Remuneration Report.
However, the Corporations Act also gives Shareholders the opportunity to remove the Board
if the Remuneration Report receives a ‘no’ vote of 25% or more at two consecutive annual
general meetings (Two Strikes Rule).
Under the Two Strikes Rule, where a resolution on the Remuneration Report receives a ‘no’
vote of 25% or more at two consecutive annual general meetings, the Company will be
required to put to Shareholders at the second annual general meeting a resolution on whether
another meeting should be held (within 90 days) at which all Directors (other than the
managing director) who were in office at the date of approval of the applicable Directors’
Report will cease to hold office immediately before that further meeting but may stand for reelection.
At the Company’s previous annual general meeting the votes cast against the Remuneration
Report considered at that annual general meeting were less than 25%. Accordingly, a further
resolution relating to the Two Strikes Rule is not relevant for this Annual General Meeting.
The Chair will allow a reasonable opportunity for Shareholders as a whole to ask about, or
make comments on the Remuneration Report.
The Chair intends to exercise all undirected proxies in favour of Resolution 1. If the Chair of
the Meeting is appointed as your proxy and you have not specified the way the Chair is to
vote on Resolution 1, by signing and returning the Proxy Form, the Shareholder is considered
to have provided the Chair with an express authorisation for the Chair to vote the proxy in
accordance with the Chair’s intention.
5.
Resolution 2 – Re-election of Director – David Lees
General
Clause 6.3 of the Constitution requires that at the Company’s annual general meeting in every
year, one-third of the Directors for the time being, or, if their number is not a multiple of 3,
then the number nearest one-third (rounded down to the nearest whole number), shall retire
from office, provided always that no Director (except a managing director) shall hold office
for a period in excess of 3 years, or until the third annual general meeting following his or her
appointment, whichever is the longer, without submitting himself or herself for re-election.
The Directors to retire at an annual general meeting are those who have been longest in the
office since their last election, but, as between persons who became Directors on the same
day, those to retire shall (unless they otherwise agree among themselves) be determined by
drawing lots.
A Director who retires by rotation under clause 6.3 of the Constitution is eligible for reelection.
David Lees (Mr Lees) will retire in accordance with clause 6.3 of the Constitution and being
eligible, seeks re-election.
Qualifications and other material directorships
Mr Lees has over 20 years’ experience in the Australian financial services industry starting
his career as a stockbroker before moving into investment and funds management. These
roles have given Mr Lees extensive experience with capital markets, portfolio management,
business development and corporate governance.
Mr Lees holds a Bachelor of Economics degree from Murdoch University and a post graduate
diploma in Applied Finance and Investment (FINSIA).
Mr Lees is the non-executive Chairman of ASX listed company C29 Metals Ltd (ASX: C29)
and also serves on the Boards of CSE listed Graycliff Exploration Ltd (CSE: GRAY) and
Puranium Energy Ltd (CSE: UX).
Independence
If re-elected the Board considers Mr Lees will be an independent director.
Board recommendation
The Board (excluding Mr Lees) recommends that Shareholders vote in favour of
Resolution 2. The Chair of the meeting intends to vote undirected proxies in favour of
Resolution 2.
6.
Resolution 3 – Approval of 10% Placement Facility
General
Listing Rule 7.1A enables eligible entities to issue Equity Securities up to 10% of its issued
share capital through placements commencing from the date of the Meeting where the
Company obtains the approval until the earlier of the following:
(a)
the date that is 12 months after the date of the Meeting at which the approval is
obtained;
(b)
the time and date of the Company’s next annual general meeting; or
(c)
the time and date of the approval of Shareholders of a transaction under Listing Rule
11.1.2 or 11.2 in respect of the Company,
(10% Placement Facility). The 10% Placement Facility is in addition to the Company’s 15%
placement capacity under Listing Rule 7.1.
An eligible entity for the purposes of Listing Rule 7.1A is an entity that is not included in the
S&P/ASX 300 Index and has a market capitalisation of $300 million or less. The Company
currently has a market capitalisation of approximately $3,111,991million and is an eligible
entity.
The Company is now seeking Shareholder approval by way of a special resolution to have
the ability to issue Equity Securities under the 10% Placement Facility.
The exact number of Equity Securities to be issued under the 10% Placement Facility will be
determined in accordance with the formula prescribed in Listing Rule 7.1A.2 (refer Section
6.2(c) below).
Description of Listing Rule 7.1A
(a)
Shareholder approval
The ability to issue Equity Securities under the 10% Placement Facility is subject to
shareholder approval by way of a special resolution at an annual general meeting.
Accordingly, at least 75% of votes cast by Shareholders present and eligible to vote
at the Meeting must be in favour of Resolution 3 for it to be passed.
(b)
Equity Securities
Any Equity Securities issued under the 10% Placement Facility must be in the same
class as an existing quoted class of Equity Securities of the Company.
The Company, as at the date of the Notice, has on issue one class of quoted Equity
Securities, being Shares (ASX: SLZ).
(c)
Formula for calculating 10% Placement Facility
Listing Rule 7.1A.2 provides that eligible entities which have obtained shareholder
approval at an annual general meeting any issue or agree to issue, during the 12
month period after the annual general meeting, a number of Equity Securities
calculated in accordance with the following formula:
(A x D) – E
Where:
A
is the number of fully paid ordinary securities on issue at the commencement
of the relevant period:
(A)
plus the number of fully paid shares issued in relevant period under an
exception in Listing Rule 7.2 other than Exception 9,16 or 17;
(B)
plus the number of fully paid shares issued in relevant period on
conversion of convertible securities within Listing Rule 7.2 Exception 9
where:
(C)
(D)
(1)
the convertible securities were issued or agreed to be issued
before the commencement of the relevant period; or
(2)
the issue of, or agreement to issue, the convertible securities
approved, or taken to have been approved, under Listing Rule
7.1 or 7.4;
plus the number of fully paid shares issued in relevant period under an
agreement to issue securities within Listing Rule 7.2 Exception 16
where:
(1)
the agreement was entered into before the commencement of
the relevant period; or
(2)
the agreement or issue was approved, or taken under these
rules to have been approved, under Listing Rule 7.1 or 7.4;
plus the number of fully paid shares issued in the 12 months
immediately preceding the issue or agreement with approval under
Listing Rule 7.1 or 7.4;
(E)
plus the number of partly paid shares that became fully paid in the 12
months immediately preceding the issue or agreement;
(F)
less the number of fully paid shares cancelled in the 12 months
immediately preceding the issue or agreement.
Note that A has the same meaning in Listing Rule 7.1 when calculating an
entity’s 15% placement capacity.
D
is 10%.
E
is the number of Equity Securities issued or agreed to be issued under Listing
Rule 7.1A.2 in the 12 month period immediately preceding the date of the issue or
agreement, where the issue or agreement has not been subsequently approved by
the holders of its ordinary securities under rule 7.4.
(d)
Listing Rule 7.1A and Listing Rule 7.3A
The ability of an entity to issue Equity Securities under Listing Rule 7.1A is in addition
to the entity’s 15% placement capacity under Listing Rule 7.1.
At the date of this Notice, the Company has on issue 148,190,049 Shares and
therefore has a capacity to issue:
(i)
22,228,507 Equity Securities under Listing Rule 7.1; and
(ii)
14,819,004 Equity Securities under Listing Rule 7.1A.
The actual number of Equity Securities that the Company will have capacity to issue
under Listing Rule 7.1A will be calculated at the date of issue of the Equity Securities
in accordance with the formula prescribed in Listing Rule 7.1A.2 (refer to Section
6.2(c) above).
(e)
Minimum Issue Price
The issue price of Equity Securities issued under Listing Rule 7.1A must be not less
than 75% of the VWAP of Equity Securities in the same class calculated over the 15
Trading Days on which trades in that class were recorded immediately before:
(f)
(i)
the date on which the price at which the Equity Securities are to be issued is
agreed; or
(ii)
if the Equity Securities are not issued within 10 Trading Days of the date in
paragraph (i) above, the date on which the Equity Securities are issued.
10% Placement Period
Shareholder approval of the 10% Placement Facility under Listing Rule 7.1A is valid
from the date of the Meeting at which the approval is obtained and expires on the
earlier to occur of:
(i)
the date that is 12 months after the date of the Meeting at which the approval
is obtained; or
(ii)
the time and date of the Company’s next annual general meeting; or
(iii)
the date of the approval by shareholders of the eligible entity’s ordinary
securities of a transaction under Listing Rules 11.1.2 (a significant change to
the nature or scale of activities) or 11.2 (disposal of main undertaking),
(10% Placement Period).
Listing Rule 7.1A
The effect of Resolution 3 will be to allow the Directors to issue the Equity Securities under
Listing Rule 7.1A during the 10% Placement Period without using the Company’s 15%
placement capacity under Listing Rule 7.1.
Resolution 3 is a special resolution and therefore requires approval of 75% of the votes cast
by Shareholders present and eligible to vote (in person, by proxy, by attorney or, in the case
of a corporate Shareholder, by a corporate representative) on the Resolution.
Specific information required by Listing Rule 7.3A
Pursuant to and in accordance with Listing Rule 7.3A, information is provided in relation to
the approval of the 10% Placement Facility as follows:
(a)
(b)
The Equity Securities will be issued at an issue price of not less than 75% of the
VWAP for the Company’s Equity Securities over the 15 Trading Days on which trades
in that class were recorded immediately before:
(i)
the date on which the price at which the Equity Securities are to be issued is
agreed; or
(ii)
if the Equity Securities are not issued within 10 Trading Days of the date in
paragraph (i) above, the date on which the Equity Securities are issued.
If Resolution 3 is approved by Shareholders and the Company issues Equity
Securities under the 10% Placement Facility, the existing Shareholders’ voting power
in the Company will be diluted as shown in the below table (in the case of Listed
Options, only if the Listed Options are exercised). There is a risk that:
(i)
the market price for the Company’s Equity Securities in that class may be
significantly lower on the date of the issue of the Equity Securities than of the
date of the Meeting; and
(ii)
the Equity Securities may be issued at a price that is at a discount to the market
price for the Company’s Equity Securities on the issue date,
which may have an effect on the amount of funds raised by the issue of the Equity
Securities.
The below table shows the dilution of existing Shareholders on the basis of the current
market price of Shares and the current number of ordinary securities for variable “A”
calculated in accordance with the formula in Listing Rule 7.1A(2) as at the date of this
Notice.
The table shows:
(i)
two examples where variable “A” has increased, by 50% and 100%. Variable
“A” is based on the number of ordinary securities the Company has on issue.
The number of ordinary securities on issue may increase as a result of issues
of ordinary securities that do not require Shareholder approval (for example, a
pro rata entitlements issue or scrip issued under a takeover offer) or future
specific placements under Listing Rule 7.1 that are approved at a future
Shareholders’ meeting; and
(ii)
two examples of where the issue price or ordinary securities has decreased
by 50% and increased by 100% as against the current market price.
Variable “A” in Listing Rule 7.1A.2
Current Variable “A”
148,190,049 Shares
10% Voting
Dilution
Funds
raised
50% increase in
current Variable “A
222,285,074 Shares
100% increase in
current Variable “A”
296,380,098 Shares
10% Voting
Dilution
Funds
raised
10% Voting
Dilution
Funds
raised
Dilution
$0.0105
$0.021
$0.04
50% decrease
in Issue Price
Issue Price
100% increase in
Issue Price
14,819,005
Shares
14,819,005
Shares
14,819,005 Shares
$155,600
$311,199
$622,398
22,228,507
Shares
22,228,507
Shares
22,228,507 Shares
$233,399
$466,799
$933,597
29,638,010
Shares
29,638,010
Shares
29,638,010 Shares
$311,199
$622,398
$1,244,796
Note
The table has been prepared on the following assumptions:
1.
The Company issues the maximum number of Equity Securities available under the 10% Placement
Facility.
2.
No Options (including any Options issued under the 10% Placement Facility) are exercised into Shares
before the date of the issue of the Equity Securities;
3.
The 10% voting dilution reflects the aggregate percentage dilution against the issued share capital at the
time of issue. This is why the voting dilution is shown in each example at 10%.
4.
The table does not show an example of dilution that may be caused to a particular Shareholder by reason
of placements under the 10% Placement Facility, based on the Shareholder’s holding at the date of the
Meeting.
5.
The table shows only the effect of issue of Equity Securities under Listing Rule 7.1A, not under the 15%
placement capacity under Listing Rule 7.1.
6.
The issue of Equity Securities under the 10% Placement Facility consists only of Shares. If the issue of
Equity Securities includes Listed Options, it is assumed that those Listed Options are exercised into Shares
for the purpose of calculating the voting dilution effect on existing Shareholders.
7.
The issue price is $0.021, being the closing price of the Shares on ASX on 27 September 2023.
(c)
The Company will only issue and allot the Equity Securities during the 10% Placement
Period. The approval under Resolution 3 for the issue of the Equity Securities will
Share your feedback
Discover